SlideShare a Scribd company logo
1 of 1
Types of Bacteria
• Streptococcus agalactiae group B
• Escherichia coli
• Haemophilus influenzae
• Streptococcus pneumoniae
• Neisseria meningitidis
• Listeria monocytogenes
• Gram-negative bacilli (Mahon, Lehman, & Manuselis,
2015)
What is Bacterial Meningitis?
Who is affected?
Signs and Symptoms
• High fever
• Headache
• Stiff Neck
• Altered Mental Status (CDC, 2016)
How is Bacterial Meningitis diagnosed?
How is Bacterial Meningitis treated?
How can we prevent Bacterial Meningitis?
Vaccinations
Policies and Legislation
State Regulations
• As of 2012, 39 states have one or more
laws that require bacterial meningitis
vaccinations.
• The main groups targeted consist of first
year college students and young
adolescents.
(NCSL, n.d.)
Questions/Comments?
Risk Factors
• Age of patient
• Large gatherings of individuals such as college
dormitories or military training
• Medical conditions that weaken the immune system
• Laboratory professionals working with pathogens
• Traveling to endemic areas with known pathogens
(CDC, 2016)
Bacteria Invasion! Bacterial Meningitis
HSCI 6264
Brandon D. Morrow (MLT ASCP)
• Nausea
• Vomiting
• Photophobia
Diagnostic Tools
• CSF culture
• CSF turbidity
• CSF glucose level
• CSF cell count
• CSF gram stain
(Mahon, Lehman, & Manuselis, 2015; Wu et al., 2013)
• Latex Agglutination
Testing
• Multiplex polymerase
chain reaction (PCR)
(Hasbun & Bronze, 2016)
Healthy Habits
• No Smoking/Alcohol
• Getting enough sleep
• Diet and Exercise
• Avoiding those with potential
for infection
Federal Law
In 2011, House of Representatives
member Kevin Brady (R-TX)
proposed a law to honor victims of
bacterial meningitis but it was not
enacted as of 2013. (Brady, n.d.)
(Meningococcal Vaccine, n.d.).

More Related Content

What's hot

Review of key concepts in clinical trial methodology
Review of key concepts in clinical trial methodology Review of key concepts in clinical trial methodology
Review of key concepts in clinical trial methodology EURORDIS Rare Diseases Europe
 
Personalized medicine 2016 brochure europe
Personalized medicine 2016 brochure   europePersonalized medicine 2016 brochure   europe
Personalized medicine 2016 brochure europePersonalized Medicine
 
Developing Urban Health Indicators for Low Income Countries: A Case Study
Developing Urban Health Indicators for Low Income Countries: A Case StudyDeveloping Urban Health Indicators for Low Income Countries: A Case Study
Developing Urban Health Indicators for Low Income Countries: A Case Studysteelss
 
Cohort studies..NIKHNA JAYAN
Cohort studies..NIKHNA JAYANCohort studies..NIKHNA JAYAN
Cohort studies..NIKHNA JAYANNikhna jayan
 
Plm science ( 14162055 )
Plm science ( 14162055 )Plm science ( 14162055 )
Plm science ( 14162055 )mahatodebola
 
Culminating Project Defense Presentation
Culminating Project Defense PresentationCulminating Project Defense Presentation
Culminating Project Defense PresentationTracy Middleton
 
York 2.11.14 slideshare copy
York 2.11.14 slideshare copyYork 2.11.14 slideshare copy
York 2.11.14 slideshare copyanoyce
 
18 setiya 2014 abstract over the counter drugs
18 setiya 2014 abstract over the counter drugs18 setiya 2014 abstract over the counter drugs
18 setiya 2014 abstract over the counter drugsAman Setiya
 
Dr. Brian Lubbers - Looking ahead: Science and Data Needs
Dr. Brian Lubbers - Looking ahead: Science and Data NeedsDr. Brian Lubbers - Looking ahead: Science and Data Needs
Dr. Brian Lubbers - Looking ahead: Science and Data NeedsJohn Blue
 

What's hot (12)

Review of key concepts in clinical trial methodology
Review of key concepts in clinical trial methodology Review of key concepts in clinical trial methodology
Review of key concepts in clinical trial methodology
 
Personalized medicine 2016 brochure europe
Personalized medicine 2016 brochure   europePersonalized medicine 2016 brochure   europe
Personalized medicine 2016 brochure europe
 
Developing Urban Health Indicators for Low Income Countries: A Case Study
Developing Urban Health Indicators for Low Income Countries: A Case StudyDeveloping Urban Health Indicators for Low Income Countries: A Case Study
Developing Urban Health Indicators for Low Income Countries: A Case Study
 
Cohort studies..NIKHNA JAYAN
Cohort studies..NIKHNA JAYANCohort studies..NIKHNA JAYAN
Cohort studies..NIKHNA JAYAN
 
Plm science ( 14162055 )
Plm science ( 14162055 )Plm science ( 14162055 )
Plm science ( 14162055 )
 
Culminating Project Defense Presentation
Culminating Project Defense PresentationCulminating Project Defense Presentation
Culminating Project Defense Presentation
 
York 2.11.14 slideshare copy
York 2.11.14 slideshare copyYork 2.11.14 slideshare copy
York 2.11.14 slideshare copy
 
Biothecnology
BiothecnologyBiothecnology
Biothecnology
 
descriptive epidemiology
descriptive epidemiologydescriptive epidemiology
descriptive epidemiology
 
Certificate (1)
Certificate (1)Certificate (1)
Certificate (1)
 
18 setiya 2014 abstract over the counter drugs
18 setiya 2014 abstract over the counter drugs18 setiya 2014 abstract over the counter drugs
18 setiya 2014 abstract over the counter drugs
 
Dr. Brian Lubbers - Looking ahead: Science and Data Needs
Dr. Brian Lubbers - Looking ahead: Science and Data NeedsDr. Brian Lubbers - Looking ahead: Science and Data Needs
Dr. Brian Lubbers - Looking ahead: Science and Data Needs
 

Similar to Morrow FinalEpiProject

2015 2-23 Oxford Global 2015 Manchester
2015 2-23 Oxford Global 2015 Manchester2015 2-23 Oxford Global 2015 Manchester
2015 2-23 Oxford Global 2015 ManchesterAlain van Gool
 
Theses Defense ppt
Theses Defense pptTheses Defense ppt
Theses Defense pptgulnazbanu7
 
Where AI will (and won't) revolutionize biomedicine
Where AI will (and won't) revolutionize biomedicineWhere AI will (and won't) revolutionize biomedicine
Where AI will (and won't) revolutionize biomedicinePaul Agapow
 
Health concerns in refugee camps group one presentation
Health concerns in refugee camps   group one presentationHealth concerns in refugee camps   group one presentation
Health concerns in refugee camps group one presentationkatherinelmacgregor
 
A Level 10 Infectious diseases.pptx
A Level 10 Infectious diseases.pptxA Level 10 Infectious diseases.pptx
A Level 10 Infectious diseases.pptxRobinGinting3
 
Knowledge and awareness of hiv among high school students in baguio city
Knowledge and awareness of hiv among high school students in baguio cityKnowledge and awareness of hiv among high school students in baguio city
Knowledge and awareness of hiv among high school students in baguio citySamuel Trinity
 
Engaging Patients in Antimicrobial Resistance and Stewardship
Engaging Patients in Antimicrobial Resistance and StewardshipEngaging Patients in Antimicrobial Resistance and Stewardship
Engaging Patients in Antimicrobial Resistance and StewardshipCanadian Patient Safety Institute
 
Microbiome Initiatives and Resources
Microbiome Initiatives and ResourcesMicrobiome Initiatives and Resources
Microbiome Initiatives and Resources uchicagotech
 
Vaccine Hesitancy in the United States
Vaccine Hesitancy in the United States Vaccine Hesitancy in the United States
Vaccine Hesitancy in the United States Sarah Thomson
 
Global Health Education—Global Health Programs: Nicholas Comninellis
Global Health Education—Global Health Programs: Nicholas ComninellisGlobal Health Education—Global Health Programs: Nicholas Comninellis
Global Health Education—Global Health Programs: Nicholas ComninellisUWGlobalHealth
 
tuberculosis Day 2022 ppt.pptx
tuberculosis Day 2022 ppt.pptxtuberculosis Day 2022 ppt.pptx
tuberculosis Day 2022 ppt.pptxanjalatchi
 
eHealth_Challenges_and_Opportunities.ppt
eHealth_Challenges_and_Opportunities.ppteHealth_Challenges_and_Opportunities.ppt
eHealth_Challenges_and_Opportunities.pptAlexandruGasnas1
 

Similar to Morrow FinalEpiProject (20)

2015 2-23 Oxford Global 2015 Manchester
2015 2-23 Oxford Global 2015 Manchester2015 2-23 Oxford Global 2015 Manchester
2015 2-23 Oxford Global 2015 Manchester
 
Theses Defense ppt
Theses Defense pptTheses Defense ppt
Theses Defense ppt
 
Where AI will (and won't) revolutionize biomedicine
Where AI will (and won't) revolutionize biomedicineWhere AI will (and won't) revolutionize biomedicine
Where AI will (and won't) revolutionize biomedicine
 
Descriptive epidemiology
Descriptive epidemiologyDescriptive epidemiology
Descriptive epidemiology
 
Health concerns in refugee camps group one presentation
Health concerns in refugee camps   group one presentationHealth concerns in refugee camps   group one presentation
Health concerns in refugee camps group one presentation
 
Science, Abstinence, and Nonsense: Ideological Threats to Public Health
Science, Abstinence, and Nonsense: Ideological Threats to Public HealthScience, Abstinence, and Nonsense: Ideological Threats to Public Health
Science, Abstinence, and Nonsense: Ideological Threats to Public Health
 
A Level 10 Infectious diseases.pptx
A Level 10 Infectious diseases.pptxA Level 10 Infectious diseases.pptx
A Level 10 Infectious diseases.pptx
 
The md program @ aimu
The md program @ aimuThe md program @ aimu
The md program @ aimu
 
Knowledge and awareness of hiv among high school students in baguio city
Knowledge and awareness of hiv among high school students in baguio cityKnowledge and awareness of hiv among high school students in baguio city
Knowledge and awareness of hiv among high school students in baguio city
 
HIV today
HIV todayHIV today
HIV today
 
Engaging Patients in Antimicrobial Resistance and Stewardship
Engaging Patients in Antimicrobial Resistance and StewardshipEngaging Patients in Antimicrobial Resistance and Stewardship
Engaging Patients in Antimicrobial Resistance and Stewardship
 
Noon conference ja 01-31-18
Noon conference ja 01-31-18Noon conference ja 01-31-18
Noon conference ja 01-31-18
 
Microbiome Initiatives and Resources
Microbiome Initiatives and ResourcesMicrobiome Initiatives and Resources
Microbiome Initiatives and Resources
 
Antibiotic resistances
Antibiotic  resistancesAntibiotic  resistances
Antibiotic resistances
 
Vaccine Hesitancy in the United States
Vaccine Hesitancy in the United States Vaccine Hesitancy in the United States
Vaccine Hesitancy in the United States
 
IAS Microbiome 5.pptx
IAS Microbiome 5.pptxIAS Microbiome 5.pptx
IAS Microbiome 5.pptx
 
Global Health Education—Global Health Programs: Nicholas Comninellis
Global Health Education—Global Health Programs: Nicholas ComninellisGlobal Health Education—Global Health Programs: Nicholas Comninellis
Global Health Education—Global Health Programs: Nicholas Comninellis
 
tuberculosis Day 2022 ppt.pptx
tuberculosis Day 2022 ppt.pptxtuberculosis Day 2022 ppt.pptx
tuberculosis Day 2022 ppt.pptx
 
eHealth_Challenges_and_Opportunities.ppt
eHealth_Challenges_and_Opportunities.ppteHealth_Challenges_and_Opportunities.ppt
eHealth_Challenges_and_Opportunities.ppt
 
English. Dr. Elizabeth Maloney
English. Dr. Elizabeth MaloneyEnglish. Dr. Elizabeth Maloney
English. Dr. Elizabeth Maloney
 

Morrow FinalEpiProject

  • 1. Types of Bacteria • Streptococcus agalactiae group B • Escherichia coli • Haemophilus influenzae • Streptococcus pneumoniae • Neisseria meningitidis • Listeria monocytogenes • Gram-negative bacilli (Mahon, Lehman, & Manuselis, 2015) What is Bacterial Meningitis? Who is affected? Signs and Symptoms • High fever • Headache • Stiff Neck • Altered Mental Status (CDC, 2016) How is Bacterial Meningitis diagnosed? How is Bacterial Meningitis treated? How can we prevent Bacterial Meningitis? Vaccinations Policies and Legislation State Regulations • As of 2012, 39 states have one or more laws that require bacterial meningitis vaccinations. • The main groups targeted consist of first year college students and young adolescents. (NCSL, n.d.) Questions/Comments? Risk Factors • Age of patient • Large gatherings of individuals such as college dormitories or military training • Medical conditions that weaken the immune system • Laboratory professionals working with pathogens • Traveling to endemic areas with known pathogens (CDC, 2016) Bacteria Invasion! Bacterial Meningitis HSCI 6264 Brandon D. Morrow (MLT ASCP) • Nausea • Vomiting • Photophobia Diagnostic Tools • CSF culture • CSF turbidity • CSF glucose level • CSF cell count • CSF gram stain (Mahon, Lehman, & Manuselis, 2015; Wu et al., 2013) • Latex Agglutination Testing • Multiplex polymerase chain reaction (PCR) (Hasbun & Bronze, 2016) Healthy Habits • No Smoking/Alcohol • Getting enough sleep • Diet and Exercise • Avoiding those with potential for infection Federal Law In 2011, House of Representatives member Kevin Brady (R-TX) proposed a law to honor victims of bacterial meningitis but it was not enacted as of 2013. (Brady, n.d.) (Meningococcal Vaccine, n.d.).